RGC Stock Summary and Trading Ideas (Regencell Bioscience Holdings Limited - | NASDAQ:RGC)

Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.

Regencell Bioscience Holdings Limited - trades on the NASDAQ stock market under the symbol RGC.

As of October 19, 2026, RGC stock price climbed to $10.05 with 821,719 million shares trading.

RGC has a beta of 2.02, meaning it tends to be more sensitive to market movements. RGC has a correlation of 0.03 to the broad based SPY ETF.

RGC has a market cap of $4.98 billion. This is considered a Mid Cap stock.

In the last 3 years, RGC traded as high as $83.60 and as low as $.08.

The top ETF exchange traded funds that RGC belongs to (by Net Assets): ONEQ, GXC.

RGC has underperformed the market in the last year with a return of -42.3%, while SPY returned +16.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RGC shares. However, RGC has outperformed the market in the last 3 month and 2 week periods, returning +100.2% and +38.8%, while SPY returned +3.4% and -1.1%, respectively. This indicates RGC has been having a stronger performance recently.

RGC support price is $8.77 and resistance is $10.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RGC shares will trade within this expected range on the day.